Yissum Research Development Company of the Hebrew University of Jerusalem Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Yissum Research Development Company of the Hebrew University of Jerusalem Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10818
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC), a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketing and licensing the inventions, products, and technologies developed by the university’s faculty, staff, researchers, and students. Its products include exelon, doxil, cherry tomatoes and long shelf-life tomatoes, granagard, osmoter x6 facial serum, hybrid peppers, hygia nutrients, artichoke, cationorm, agcite, vuze, melon, periochip, ikervis, explora, superior ceramic ink, uv-pearl, seer, and bioresorbable adhesion barrier. YRDC transfers the technologies in various fields including computer science, medicine and pharmaceuticals, nanotechnology, water and environmental technologies, agriculture and nutrition, homeland security, and others. The company supports business partners in identifying the researcher to conduct the research and tailor the partnerships to the requirements of the business partner and the technologies. YRDC is headquartered in Jerusalem, Israel.

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deal Details 14
Venture Financing 14
Atox Bio Raises USD30 Million in Financing 14
Avraham Pharma Raises up to USD4.5 Million Financing 16
Avraham Pharma Raises USD4.5 Million in Venture Financing 17
Avraham Pharma Raises US$6 Million In Venture Financing 19
Integra Holdings Raises US$7 Million In First Round Financing 20
Partnerships 21
Phytecs Enters into Agreement with Yissum Research Development 21
Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 22
Accurexa Enters into Agreement with Yissum Research Development 23
Yissum Research Development Expands Licensing Agreement with Israel Chemicals 24
Licensing Agreements 25
BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 25
Spherium Biomed Enters into Option Agreement with Yissum 26
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 27
BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 28
Immune Pharma Enters into Licensing Agreement with Yissum 29
Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 31
Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 32
Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 33
BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 34
Acquisition 36
Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 36
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Key Competitors 37
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Key Employees 38
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Atox Bio Raises USD30 Million in Financing 14
Avraham Pharma Raises up to USD4.5 Million Financing 16
Avraham Pharma Raises USD4.5 Million in Venture Financing 17
Avraham Pharma Raises US$6 Million In Venture Financing 19
Integra Holdings Raises US$7 Million In First Round Financing 20
Phytecs Enters into Agreement with Yissum Research Development 21
Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 22
Accurexa Enters into Agreement with Yissum Research Development 23
Yissum Research Development Expands Licensing Agreement with Israel Chemicals 24
BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 25
Spherium Biomed Enters into Option Agreement with Yissum 26
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 27
BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 28
Immune Pharma Enters into Licensing Agreement with Yissum 29
Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 31
Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 32
Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 33
BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 34
Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 36
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Key Competitors 37
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Key Employees 38
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Subsidiaries 39

List of Figures
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Yissum Research Development Company of the Hebrew University of Jerusalem Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Inox Wind Limited (INOXWIND):企業のM&A・提携動向(エネルギー分野)
    Summary Inox Wind Limited (IWL), a subsidiary of Gujarat Fluorochemicals Limited, is a manufacturer of wind turbine generators. The company manufactures and markets wind turbine generators of 2 MW. Through its subsidiary, it also offers turnkey solutions such as wind resource assessment, site acquis …
  • Taikoo (Xiamen) Aircraft Engineering Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Taikoo (Xiamen) Aircraft Engine …
  • Samba Financial Group (1090):企業の財務・戦略的SWOT分析
    Samba Financial Group (1090) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Baraka Energy & Resources Limited (BKP):企業のM&A・提携動向(石油・ガス分野)
    Summary Baraka Energy & Resources Limited (Baraka Energy), formerly Baraka Petroleum Limited is an oil and gas company that offers exploration services. The company identifies, explores and develops energy and resource assets. It has oil and gas assets in Georgina Basin in the Northern Territory, on …
  • Pharmacyclics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmacyclics Inc (Pharmacyclics), a wholly-owned subsidiary of AbbVie, discovers, develops and commercializes novel therapies for the treatment of cancer and immunemediated diseases. The company’s drugs and drug candidates are synthetic small-molecules that target major biochemical pathways …
  • American Family Insurance Group:企業の戦略・SWOT・財務分析
    SummaryAmerican Family Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • Silverlake Axis Ltd.:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Silverlake Axis Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly foll …
  • CTC Bio, Inc.の企業概要及び財務/SWOT分析
    CTC Bio, Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecas …
  • Stratton Resources Inc. (SI):企業概要、財務及び戦略的SWOT分析
    Summary Stratton Resources Inc. (Stratton) is a mineral exploration company. The company’s operates through acquisition, exploration and development of precious, base metal and uranium properties. It holds projects such as Mac Molybdenum, which is an advanced-stage exploration Molybdenum-Copper proj …
  • Xinjiang Zhongtai Chemical (Group) Co., Ltd. (002092):企業の財務及び戦略的SWOT分析
    Summary Xinjiang Zhongtai Chemical (Group) Co., Ltd. (Zhongtai Chemical) is a chemical manufacturing company that trades industrial chemicals. The company offers products such as SG3-SG8 polyvinyl chloride, polyvinyl chloride resins, industrial chemicals, caustic soda flakes, caustic soda pearls, hy …
  • Mid-America Apartment Communities Inc (MAA):企業財務及び戦略的SWOT分析
    Summary Mid-America Apartment Communities Inc (MAA) is a real estate investment company that operates apartment homes. The company’s activities include acquisition, selective development, redevelopment and management of multifamily homes. It offers services including apartments with golf and civil r …
  • KM Corporation (083550):企業財務及び戦略的SWOT分析
    Summary KM Corporation (KM) is a medical device company that manufactures and markets disposable products. The company provides clean-room products, industrial goods and garments. Its clean-room and industrial products comprise gloves, wipers, stationery, cleaners, respirators, eye, ear and skin saf …
  • Continental AG:戦略・SWOT・企業財務分析
    Continental AG - Strategy, SWOT and Corporate Finance Report Summary Continental AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Golden Entertainment, Inc.:企業の戦略・SWOT・財務分析
    SummaryGolden Entertainment, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • EBX Group:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EBX Group Mergers and Acquisiti …
  • Brokk AB:企業の戦略的SWOT分析
    Brokk AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Iberia Lineas Aereas de Espana, SA:企業の戦略・SWOT・財務分析
    SummaryIberia Lineas Aereas de Espana, SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …
  • Blade Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Blade Therapeutics Inc (Blade Therapeutics) is a biopharmaceutical company which develops novel anti-fibrotic therapies to treat various fibrotic disorders. Its lead program is a small molecule inhibitor targeting an intracellular cysteine protease associated with fibrosis across diverse ind …
  • Guararapes Confeccoes SA:企業の戦略・SWOT・財務分析
    SummaryGuararapes Confeccoes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Hyperdynamics Corporation (HDYN):企業の財務及び戦略的SWOT分析
    Summary Hyperdynamics Corporation (Hyperdynamics) is an oil and gas company that offers exploration services. The company provides exploration and production services. It acquires, explores and develops oil and gas properties in the Republic of Guinea, Northwest Africa. The company also offers drill …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆